Christodoulou, S.; Katsaraki, K.; Vassiliu, P.; Danias, N.; Michalopoulos, N.; Tzikos, G.; Sideris, D.C.; Arkadopoulos, N.
High Intratumoral i-tRF-GlyGCC Expression Predicts Short-Term Relapse and Poor Overall Survival of Colorectal Cancer Patients, Independent of the TNM Stage. Biomedicines 2023, 11, 1945.
https://doi.org/10.3390/biomedicines11071945
AMA Style
Christodoulou S, Katsaraki K, Vassiliu P, Danias N, Michalopoulos N, Tzikos G, Sideris DC, Arkadopoulos N.
High Intratumoral i-tRF-GlyGCC Expression Predicts Short-Term Relapse and Poor Overall Survival of Colorectal Cancer Patients, Independent of the TNM Stage. Biomedicines. 2023; 11(7):1945.
https://doi.org/10.3390/biomedicines11071945
Chicago/Turabian Style
Christodoulou, Spyridon, Katerina Katsaraki, Panteleimon Vassiliu, Nikolaos Danias, Nikolaos Michalopoulos, Georgios Tzikos, Diamantis C. Sideris, and Nikolaos Arkadopoulos.
2023. "High Intratumoral i-tRF-GlyGCC Expression Predicts Short-Term Relapse and Poor Overall Survival of Colorectal Cancer Patients, Independent of the TNM Stage" Biomedicines 11, no. 7: 1945.
https://doi.org/10.3390/biomedicines11071945
APA Style
Christodoulou, S., Katsaraki, K., Vassiliu, P., Danias, N., Michalopoulos, N., Tzikos, G., Sideris, D. C., & Arkadopoulos, N.
(2023). High Intratumoral i-tRF-GlyGCC Expression Predicts Short-Term Relapse and Poor Overall Survival of Colorectal Cancer Patients, Independent of the TNM Stage. Biomedicines, 11(7), 1945.
https://doi.org/10.3390/biomedicines11071945
